CTI BioPharma Corp (fka CTIC)

[paulbk]

More from Iguana Bio:

http://www.iguanabio.com/cell-therapeutics-pixantrone-status/


Its a good read for CTIC. Unfortunately the April 6 day may most likely be a bit of wishful thinking.

The important thing is the value of Pixantrone is getting noticed by people outside the stock. Unlike many of these hyped up POS's this company has a viable and important treatment months away from approval.

Here's a relevant quote;

"Novartis has an option to buy Pixantrone, but there’s no timeline commitment. Its best bet would be to take it now before the drug is approved (most likely will be) and the stock is in the $2-3 range. NVS’ only concern is the high royalties it has to pay CTIC. The cash is peanuts."

Best to all